<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0005">
 <label>Table 1</label>
 <caption>
  <p>Demographic and clinical characteristics of 539 patients hospitalised for COVID-19 disease according to in-hospital death.</p>
 </caption>
 <alt-text id="at0050">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left"/>
    <th align="left">In-hospital survival</th>
    <th align="left">In-hospital death</th>
    <th align="left">Total</th>
    <th align="left">p</th>
   </tr>
   <tr>
    <th align="left"/>
    <th align="left">N = 367 (67.7)</th>
    <th align="left">N = 174 (32.3)</th>
    <th align="left">N = 539</th>
    <th align="left"/>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">Gender, male, N (%)</td>
    <td align="left">230 (63.0)</td>
    <td align="left">117 (67.2)</td>
    <td align="left">347 (64.4)</td>
    <td align="left">0.338</td>
   </tr>
   <tr>
    <td align="left">Age, years, median (IQR)</td>
    <td align="left">60 (50–72)</td>
    <td align="left">78 (67–84)</td>
    <td align="left">66 (54–78)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td colspan="5" align="left">Age strata, years, N (%)</td>
   </tr>
   <tr>
    <td align="left"> 18–39</td>
    <td align="left">43 (11.8)</td>
    <td align="left">0 (0.0)</td>
    <td align="left">43 (8.0)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left"> 40–59</td>
    <td align="left">134 (36.7)</td>
    <td align="left">23 (13.2)</td>
    <td align="left">157 (29.1)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> 60–79</td>
    <td align="left">139 (38.1)</td>
    <td align="left">82 (47.1)</td>
    <td align="left">221 (41.0)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> ≥80</td>
    <td align="left">49 (13.4)</td>
    <td align="left">69 (39.7)</td>
    <td align="left">118 (21.9)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Ethnicity, N (%)</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left"> Caucasian</td>
    <td align="left">285 (78.1)</td>
    <td align="left">163 (93.7)</td>
    <td align="left">448 (83.1)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Latin/Hispanic</td>
    <td align="left">37 (10.1)</td>
    <td align="left">5 (2.9)</td>
    <td align="left">42 (7.8)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Black</td>
    <td align="left">8 (2.2)</td>
    <td align="left">0 (0.0)</td>
    <td align="left">8 (1.5)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Asian</td>
    <td align="left">12 (3.3)</td>
    <td align="left">3 (1.7)</td>
    <td align="left">15 (2.8)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Other</td>
    <td align="left">23 (6.3)</td>
    <td align="left">3 (1.7)</td>
    <td align="left">26 (4.8)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Risk factors, N (%)</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left"> Close contact/household</td>
    <td align="left">88 (24.1)</td>
    <td align="left">23 (13.2)</td>
    <td align="left">111 (20.6)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Healthcare worker</td>
    <td align="left">37 (10.1)</td>
    <td align="left">2 (1.2)</td>
    <td align="left">39 (7.2)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> High risk zone</td>
    <td align="left">17 (4.7)</td>
    <td align="left">10 (5.7)</td>
    <td align="left">27 (5.0)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Hospitalisation last 30 days</td>
    <td align="left">18 (4.9)</td>
    <td align="left">9 (5.2)</td>
    <td align="left">27 (5.0)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Long-term care facility</td>
    <td align="left">23 (6.3)</td>
    <td align="left">33 (19.0)</td>
    <td align="left">56 (10.4)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Unknown</td>
    <td align="left">182 (49.9)</td>
    <td align="left">97 (55.8)</td>
    <td align="left">279 (51.8)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Smoking, N (%)</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">0.001</td>
   </tr>
   <tr>
    <td align="left"> Never</td>
    <td align="left">47 (12.9)</td>
    <td align="left">6 (3.5)</td>
    <td align="left">53 (9.8)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Former</td>
    <td align="left">35 (9.6)</td>
    <td align="left">20 (11.5)</td>
    <td align="left">55 (10.2)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Actual</td>
    <td align="left">12 (3.3)</td>
    <td align="left">1 (0.6)</td>
    <td align="left">13 (2.4)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Unknown</td>
    <td align="left">271 (74.2)</td>
    <td align="left">147 (84.5)</td>
    <td align="left">418 (77.6)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Obesity, N (%)</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">0.153</td>
   </tr>
   <tr>
    <td align="left"> No</td>
    <td align="left">141 (38.4)</td>
    <td align="left">52 (30.2)</td>
    <td align="left">193 (35.8)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Yes</td>
    <td align="left">50 (13.6)</td>
    <td align="left">27 (15.8)</td>
    <td align="left">77 (14.3)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Unknown</td>
    <td align="left">174 (47.7)</td>
    <td align="left">94 (54.3)</td>
    <td align="left">268 (49.8)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td colspan="5" align="left">Number of concomitant comorbidities, N (%)</td>
   </tr>
   <tr>
    <td align="left"> 0</td>
    <td align="left">151 (41.1)</td>
    <td align="left">36 (20.7)</td>
    <td align="left">186 (34.5)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left"> 1</td>
    <td align="left">114 (31.2)</td>
    <td align="left">35 (20.1)</td>
    <td align="left">149 (27.6)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> 2</td>
    <td align="left">50 (13.7)</td>
    <td align="left">40 (23.0)</td>
    <td align="left">90 (16.7)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> 3</td>
    <td align="left">27 (7.4)</td>
    <td align="left">30 (17.2)</td>
    <td align="left">57 (10.6)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> ≥4</td>
    <td align="left">24 (6.6)</td>
    <td align="left">33 (19.0)</td>
    <td align="left">57 (10.6)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td colspan="5" align="left">Comorbidities, N (%)</td>
   </tr>
   <tr>
    <td align="left"> Hypertension</td>
    <td align="left">145 (39.7)</td>
    <td align="left">105 (60.3)</td>
    <td align="left">250 (46.4)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left"> Diabetes</td>
    <td align="left">49 (13.4)</td>
    <td align="left">46 (26.4)</td>
    <td align="left">95 (17.6)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left"> Cardiovascular diseases
     <xref rid="tblfn0005" ref-type="table-fn">a</xref>
    </td>
    <td align="left">72 (19.7)</td>
    <td align="left">75 (43.1)</td>
    <td align="left">147 (27.3)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left"> Cerebrovascular diseases
     <xref rid="tblfn0010" ref-type="table-fn">b</xref>
    </td>
    <td align="left">21 (5.7)</td>
    <td align="left">24 (13.8)</td>
    <td align="left">45 (8.3)</td>
    <td align="left">0.002</td>
   </tr>
   <tr>
    <td align="left"> Chronic obstructive pulmonary disease/asthma</td>
    <td align="left">43 (11.8)</td>
    <td align="left">31 (17.8)</td>
    <td align="left">74 (13.7)</td>
    <td align="left">0.057</td>
   </tr>
   <tr>
    <td align="left"> Chronic liver diseases/cirrhosis</td>
    <td align="left">12 (3.3)</td>
    <td align="left">7 (4.0)</td>
    <td align="left">19 (3.5)</td>
    <td align="left">0.665</td>
   </tr>
   <tr>
    <td align="left"> Solid or haematological malignancy</td>
    <td align="left">17 (4.7)</td>
    <td align="left">21 (12.1)</td>
    <td align="left">38 (7.0)</td>
    <td align="left">0.002</td>
   </tr>
   <tr>
    <td align="left"> Chronic kidney disease</td>
    <td align="left">17 (4.7)</td>
    <td align="left">24 (138)</td>
    <td align="left">41 (7.6)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left"> HIV infection/AIDS</td>
    <td align="left">3 (0.82)</td>
    <td align="left">1 (0.6)</td>
    <td align="left">4 (0.7)</td>
    <td align="left">0.755</td>
   </tr>
   <tr>
    <td align="left"> Reumathic diseases</td>
    <td align="left">6 (1.6)</td>
    <td align="left">8 (4.6)</td>
    <td align="left">14 (2.6)</td>
    <td align="left">0.044</td>
   </tr>
   <tr>
    <td align="left">Age unadjusted Charlson score, median (IQR)</td>
    <td align="left">0 (0–1)</td>
    <td align="left">1 (0–3)</td>
    <td align="left">0 (0–2)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">Days from symptoms onset to hospitalisation, median (IQR)</td>
    <td align="left">7 (3–10)</td>
    <td align="left">5 (2–8)</td>
    <td align="left">6 (3–10)</td>
    <td align="left">0.001</td>
   </tr>
   <tr>
    <td colspan="5" align="left">Signs and symptoms at admission, N (%)</td>
   </tr>
   <tr>
    <td align="left"> Fever</td>
    <td align="left">312 (85.5)</td>
    <td align="left">153 (87.9)</td>
    <td align="left">465 (86.3)</td>
    <td align="left">0.439</td>
   </tr>
   <tr>
    <td align="left"> Dyspnea</td>
    <td align="left">191 (52.3)</td>
    <td align="left">109 (62.6)</td>
    <td align="left">300 (55.7)</td>
    <td align="left">0.024</td>
   </tr>
   <tr>
    <td align="left"> Cough</td>
    <td align="left">205 (56.2)</td>
    <td align="left">67 (38.5)</td>
    <td align="left">272 (50.5)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left"> Dyspnea</td>
    <td align="left">191 (52.3)</td>
    <td align="left">109 (62.6)</td>
    <td align="left">300 (55.7)</td>
    <td align="left">0.024</td>
   </tr>
   <tr>
    <td align="left"> Asthenia</td>
    <td align="left">62 (17.0)</td>
    <td align="left">23 (14.9)</td>
    <td align="left">88 (16.3)</td>
    <td align="left">0.553</td>
   </tr>
   <tr>
    <td align="left"> Gastrointestinal symptoms</td>
    <td align="left">64 (17.5)</td>
    <td align="left">12 (6.9)</td>
    <td align="left">76 (14.1)</td>
    <td align="left">0.001</td>
   </tr>
   <tr>
    <td align="left"> Myalgia</td>
    <td align="left">24 (6.6)</td>
    <td align="left">3 (1.7)</td>
    <td align="left">27 (5.0)</td>
    <td align="left">0.016</td>
   </tr>
   <tr>
    <td align="left"> Arhytmia</td>
    <td align="left">14 (3.8)</td>
    <td align="left">12 (6.9)</td>
    <td align="left">26 (4.8)</td>
    <td align="left">0.121</td>
   </tr>
   <tr>
    <td align="left"> Chestpain</td>
    <td align="left">18 (4.9)</td>
    <td align="left">6 (3.5)</td>
    <td align="left">24 (4.4)</td>
    <td align="left">0.435</td>
   </tr>
   <tr>
    <td align="left"> Anosmia/dysgeusia</td>
    <td align="left">16 (4.4)</td>
    <td align="left">1 (0.6)</td>
    <td align="left">17 (3.1)</td>
    <td align="left">0.018</td>
   </tr>
   <tr>
    <td align="left"> Headache</td>
    <td align="left">9 (2.5)</td>
    <td align="left">2 (1.2)</td>
    <td align="left">11 (2.0)</td>
    <td align="left">0.312</td>
   </tr>
   <tr>
    <td align="left"> Other respiratory symptoms</td>
    <td align="left">18 (4.9)</td>
    <td align="left">5 (2.9)</td>
    <td align="left">23 (4.3)</td>
    <td align="left">0.269</td>
   </tr>
   <tr>
    <td align="left"> Other non respiratory symptoms</td>
    <td align="left">26 (7.1)</td>
    <td align="left">32 (18.4)</td>
    <td align="left">58 (10.8)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">COVID-19 severity at admission, N (%)</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left"> Mild</td>
    <td align="left">28 (7.7)</td>
    <td align="left">7 (4.0)</td>
    <td align="left">35 (6.5)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Moderate</td>
    <td align="left">197 (54.0)</td>
    <td align="left">45 (25.9)</td>
    <td align="left">242 (44.9)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Severe</td>
    <td align="left">137 (37.5)</td>
    <td align="left">107 (61.5)</td>
    <td align="left">244 (45.3)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Critical</td>
    <td align="left">3 (0.8)</td>
    <td align="left">15 (8.6)</td>
    <td align="left">18 (3.4)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">PO
     <sub>2</sub>/FiO
     <sub>2</sub> at admission, mmHg, median (IQR)
    </td>
    <td align="left">322 (275–371)</td>
    <td align="left">242 (150–308)</td>
    <td align="left">301 (231–352)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left"> &gt;300</td>
    <td align="left">206 (56.4)</td>
    <td align="left">42 (24.1)</td>
    <td align="left">248 (50.2)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left"> 100–300</td>
    <td align="left">131 (35.9)</td>
    <td align="left">97 (55.7)</td>
    <td align="left">228 (46.1)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> &lt;100</td>
    <td align="left">3 (0.8)</td>
    <td align="left">15 (8.6)</td>
    <td align="left">18 (3.6)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Missing</td>
    <td align="left">25 (6.8)</td>
    <td align="left">20 (11.5)</td>
    <td align="left">45 (8.3)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Respiratory rate at admission, breaths/min, median (IQR)</td>
    <td align="left">22 (18–28)</td>
    <td align="left">28 (22–32)</td>
    <td align="left">24 (20–29)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">X-ray or CT scan findings, N (%)</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">0.059</td>
   </tr>
   <tr>
    <td align="left"> No signs of pneumonia</td>
    <td align="left">33 (9.0)</td>
    <td align="left">10 (5.7)</td>
    <td align="left">43 (7.9)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Pulmanary infiltrates/ground glass opacities and lung consolidation</td>
    <td align="left">182 (49.9)</td>
    <td align="left">79 (45.4)</td>
    <td align="left">261 (48.4)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Lung consolidation</td>
    <td align="left">24 (6.6)</td>
    <td align="left">24 (13.8)</td>
    <td align="left">48 (8.9)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Pulmanary infiltrates/ground glass opacities</td>
    <td align="left">123 (33.7)</td>
    <td align="left">60 (34.5)</td>
    <td align="left">183 (33.9)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left"> Bilateral involvement</td>
    <td align="left">292 (87.9)</td>
    <td align="left">137 (83.5)</td>
    <td align="left">429 (86.5)</td>
    <td align="left">0.372</td>
   </tr>
   <tr>
    <td align="left"> Pleural effusion</td>
    <td align="left">42 (11.5)</td>
    <td align="left">27 (15.5)</td>
    <td align="left">69 (12.8)</td>
    <td align="left">0.193</td>
   </tr>
   <tr>
    <td align="left">Hemoglobin, g/dL, median (IQR)</td>
    <td align="left">13.7 (12.4–14.8)</td>
    <td align="left">13.2 (11.6–14.5)</td>
    <td align="left">13.5 (12.2–14.8)</td>
    <td align="left">0.015</td>
   </tr>
   <tr>
    <td align="left">CRP, mg/L, median (IQR)</td>
    <td align="left">46.1 (21.3–85.7)</td>
    <td align="left">87.1 (54.9–126.1)</td>
    <td align="left">60.1 (27.8–103.0)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">LDH, U/L, median (IQR)</td>
    <td align="left">273 (211–353)</td>
    <td align="left">355 (275–482)</td>
    <td align="left">296 (229–393)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">Leukocytes count, 10^3/μL, median (IQR)</td>
    <td align="left">6.35 (4.74–8.61)</td>
    <td align="left">7.06 (5.20–10.79)</td>
    <td align="left">6.56 (4.93–9.11)</td>
    <td align="left">0.001</td>
   </tr>
   <tr>
    <td align="left">Lymphocyte count, 10^3/μL, median (IQR)</td>
    <td align="left">1.09 (0.74–1.45)</td>
    <td align="left">0.80 (0.58–1.14)</td>
    <td align="left">1.01 (0.67–1.36)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">Platelets,10^3/μL, median (IQR)</td>
    <td align="left">214 (167–267)</td>
    <td align="left">192 (145–261)</td>
    <td align="left">204 (159–266)</td>
    <td align="left">0.007</td>
   </tr>
   <tr>
    <td align="left">Creatine phosphokinase, U/L, median (IQR)</td>
    <td align="left">82 (52–154)</td>
    <td align="left">140 (66–350)</td>
    <td align="left">94 (54–184)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">
     <sc>d</sc>-dimer, ng/mL, median (IQR)
    </td>
    <td align="left">305 (153–584)</td>
    <td align="left">563 (314–2340)</td>
    <td align="left">358 (170–809)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">ALT, U/L, median (IQR)</td>
    <td align="left">30 (20–52)</td>
    <td align="left">28 (19–43)</td>
    <td align="left">30 (20–49)</td>
    <td align="left">0.168</td>
   </tr>
   <tr>
    <td align="left">AST, U/L, median (IQR)</td>
    <td align="left">40 (30–56)</td>
    <td align="left">46 (32–68)</td>
    <td align="left">41 (31–60)</td>
    <td align="left">0.009</td>
   </tr>
   <tr>
    <td align="left">Creatinin, mg/dL, median (IQR)</td>
    <td align="left">0.8 (0.7–1.1)</td>
    <td align="left">1.1 (0.8–1.7)</td>
    <td align="left">0.9 (0.7–1.2)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">Procalcitonin, ng/mL, median (IQR)</td>
    <td align="left">0.1 (0.05–0.29)</td>
    <td align="left">0.69 (0.18–2.49)</td>
    <td align="left">0.18 (0.07–0.84)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">Ferritin, ng/mL median (IQR)</td>
    <td align="left">389 (182–758)</td>
    <td align="left">701 (334–1320)</td>
    <td align="left">447 (215–860)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">Pharmacological support, N (%) lopinavir/r or darunavir/c or remdesivir</td>
    <td align="left">89 (24.2)</td>
    <td align="left">45 (26.2)</td>
    <td align="left">134 (24.8)</td>
    <td align="left">0.632</td>
   </tr>
   <tr>
    <td align="left">Hydroxychloroquine ± azithromycin</td>
    <td align="left">306 (83.8)</td>
    <td align="left">121 (69.5)</td>
    <td align="left">427 (79.2)</td>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">Heparin prophylaxis</td>
    <td align="left">242 (66.3)</td>
    <td align="left">113 (64.9)</td>
    <td align="left">355 (65.9)</td>
    <td align="left">0.756</td>
   </tr>
   <tr>
    <td align="left">Corticosteroids</td>
    <td align="left">80 (21.9)</td>
    <td align="left">42 (24.1)</td>
    <td align="left">122 (22.6)</td>
    <td align="left">0.565</td>
   </tr>
   <tr>
    <td align="left">Immunomodulator (tocilizumab, sarilumab)</td>
    <td align="left">29 (7.9)</td>
    <td align="left">14 (8.1)</td>
    <td align="left">43 (8.0)</td>
    <td align="left">0.968</td>
   </tr>
   <tr>
    <td align="left">Drugs combination, N (%)</td>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">0.001</td>
   </tr>
   <tr>
    <td align="left">No drugs</td>
    <td align="left">29 (8.0)</td>
    <td align="left">22 (12.6)</td>
    <td align="left">51 (9.5)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Hydroxychloroquine + heparin (±lopinavir/r or darunavir/c or azithromycin)</td>
    <td align="left">214 (58.6)</td>
    <td align="left">87 (50.0)</td>
    <td align="left">301 (55.8)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Hydroxychloroquine + lopinavir/r or darunavir/c</td>
    <td align="left">41 (11.2)</td>
    <td align="left">11 (6.3)</td>
    <td align="left">52 (9.6)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Hydroxychloroquine ± azithromycin</td>
    <td align="left">49 (13.4)</td>
    <td align="left">23 (13.2)</td>
    <td align="left">72 (13.4)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Heparin only</td>
    <td align="left">11 (3.0)</td>
    <td align="left">18 (10.3)</td>
    <td align="left">29 (5.4)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Other combinations</td>
    <td align="left">21 (5.8)</td>
    <td align="left">13 (7.5)</td>
    <td align="left">34 (6.3)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Highest grade of O
     <sub>2</sub> therapy, N (%)
    </td>
    <td align="left"/>
    <td align="left"/>
    <td align="left"/>
    <td align="left">&lt;0.001</td>
   </tr>
   <tr>
    <td align="left">Mechanical ventilation</td>
    <td align="left">62 (17.0)</td>
    <td align="left">55 (31.6)</td>
    <td align="left">117 (21.7)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">cPAP</td>
    <td align="left">82 (22.5)</td>
    <td align="left">74 (42.5)</td>
    <td align="left">156 (28.9)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">O
     <sub>2</sub> low/high flow
    </td>
    <td align="left">159 (43.6)</td>
    <td align="left">43 (24.7)</td>
    <td align="left">202 (37.5)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">No O
     <sub>2</sub> therapy
    </td>
    <td align="left">62 (17.0)</td>
    <td align="left">2 (1.2)</td>
    <td align="left">64 (11.9)</td>
    <td align="left"/>
   </tr>
   <tr>
    <td align="left">Follow-up, median days (IQR)</td>
    <td align="left">13 (7–25)</td>
    <td align="left">6 (5–12)</td>
    <td align="left">10 (6–21)</td>
    <td align="left">&lt;0.001</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="tblfn0005">
   <label>a</label>
   <p id="npar0005">Cardiovascular diseases: coronary artery disease or congestive heart failure or vascular diseases.</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tblfn0010">
   <label>b</label>
   <p id="npar0010">Cerebrovascular diseases: stroke or transient ischemic attack or hemiplegia.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
